Announcement

Collapse
No announcement yet.

A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases

    J Infect Dis. 2018 Feb 28. doi: 10.1093/infdis/jiy103. [Epub ahead of print]
    A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.

    Erbelding EJ1, Post D2, Stemmy E2, Roberts PC2, Augustine AD3, Ferguson S3, Paules CI4, Graham BS5, Fauci AS6.
    Author information

    Abstract

    A priority for the National Institute of Allergy and Infectious Diseases (NIAID) is development of an influenza vaccine providing durable protection against multiple influenza strains, including those that may cause a pandemic, i.e., a universal influenza vaccine. To invigorate research efforts, NIAID developed a strategic plan focused on knowledge gaps in three major research areas, as well as additional resources required to ensure progress towards a universal influenza vaccine. NIAID will use this plan as a foundation for future investments in influenza research and will support and coordinate a consortium of multidisciplinary scientists focused on accelerating progress towards this goal.


    PMID: 29506129 DOI: 10.1093/infdis/jiy103
Working...
X